Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia

Seminars in Respiratory and Critical Care Medicine

Volumn 19, Issue 1, 1998, Pages 79-89

  Hughes, J M B ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Arteriovenous malformations; Hereditary hemorrhagic telangiectasia; Osler Weber Rendu syndrome

Indexed keywords

AORTA BALLOON; ARTERIOVENOUS MALFORMATION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; EPISTAXIS; GENETICS; HEART RIGHT LEFT SHUNT; HUMAN; LUNG ANGIOGRAPHY; LUNG ARTERIOVENOUS SHUNT; LUNG FUNCTION; LUNG HEMODYNAMICS; PRIORITY JOURNAL; RECURRENT DISEASE; RENDU OSLER WEBER DISEASE; SCREENING; THORAX RADIOGRAPHY;

EID: 0031919424     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1009384     Document Type: Article

References (68)

1. Hughes JM, Allison DJ. Pulmonary arteriovenous malformations: the radiologist replaces the surgeon. Clin Radiol 1990;41:297-8
2. Ference BA, Shannon TM, White RI, Zawin M, Burdge CM. Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Chest 1994;106:1387-90
3. Hughes JMB, Jackson JE, Allison DJ. Pulmonary arteriovenous malformations. In AJ Peacock (eds). Pulmonary Circulation: A Handbook for Clinicians. Chapman and Hall, London, 1996;359-376
4. Haitjema T, Westermann CJ, Overtoom TT, et al. Hereditary hemorrhagic telangiectasia (Osier-Weber-Rendu disease), new insights in pathogenesis, complications, and treatment Arch Intern Med 1996;156:714-9
5. Hughes JM Intrapulmonary shunts: coils to transplantation. J R Coll Physicians Lond 1994;28:247-53
6. Guttmacher AE, Marchuk DA, White RI. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995;333:918-24
7. Porteous ME, Burn J, Proctor SJ. Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet 1992;29: 527-30
8. Plauchu H, de Chadarévian J-P, Bideau A, Robert JM. Age-related clinical profile of Hereditary Haemorrhagic Telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989;32:291-297
9. Vase P, Holm M, Arendrup H. Pulmonary arteriovenous fistulas in hereditary haemorrhagic telangiectasia. Acta Med Scand 1985;218:105-109
10. Jessurun GA, Kamphuis DJ, van der Zande FH, Nossent JC. Cerebral arteriovenons malformations in The Netherlands Antilles. High prevalence of hereditary hemorrhagic telangiectasia-related single and multiple cerebral arteriovenous malformations. Clin Neurol Neurosurg 1993; 95:193-8
11. Braverman IM, Keh A, Jacobsen BS. Ultrastructure and three-dimensional organization of the telangiectasias of hereditary haemorrhagic telangiectasia. J Invest Dermatol 1990;95:422-427
12. Harrison DFN. Familial haemorrhagic telangiectasia - 20 cases treated with oestrogen. QJ Med 1964;33:25-38
13. Vase P. Estrogen treatment of hereditary hemorrhagic telangiectasia Acta Med Scand 1981;209:393-396
14. van Custem E, Rutgeerts P, Vantrappen G. Long-term effect of hormonal therapy for bleeding gastrointestinal malformations. Eur J Gastroenterol 1993;5:439-443
15. Saba HI, Morelli GA, Logrono LA. Brief report: treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. N Engl J Med 1994;330:1789-90
16. Korzenik JR, Topazian MD, White RI. Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid (letter). New Engl J Med 1994;331:1326
17. Shovlin CL, Winstock AJR, Peters AM, Jackson JE, Hughes JM. Medical complications of pregnancy in hereditary haemorrhagic telangiectasia. Quart J Med 1995;88:879-87
18. Steele JG, Nath PU, Burn J, Porteous ME. An association between migrainous aura and hereditary haemorrhagic telangiectasia. Headache 1993;33:145-8
19. Shovlin CL, Hughes JM, Tuddenham EG, et al. A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 1994;6:205-9
20. McDonald MT, Papenberg KA, Ghosh S, et al. A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34. Nat Genet 1994;6:197-204
21. McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994;8:345-51
22. ter. Cytogenet Cell Genet 1993;54:204-7
23. Gougos A, Letarte M. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem 1990;265:8361-4
24. Cheifetz S, Bellón T, Cales C, et al. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J Biol Chem 1992;267:19027-30
25. Zhang H, Shaw ARE, Mak A, Letarte M. Endoglin is a component of the transforming growth facotr (TGF)-β receptor complex of human pre-B leukemic cells. J Immunol 1996;56:565-573
26. Yamashita H, Ichijoro H, Grimsby S, et al. Endoglin forms a hetomeric complex with the signalling receptors for transforming growth factor-β. J Biol Chem 1994;269:1995-2001
27. Lastres P, Letamendia A, Zhang H, et al. Endoglin modulates cellular responses to TGF-β1. J Cell Biol 1996;133:1109-21
28. Bellón T, Corbi A, Lastres P, et al. Identification and expression of two forms of the human transforming growth factor-β-binding protein endoglin with distinct cytoplasmic domains. Eur J Immunol 1993;23:2340-45
29. Massagué J, Attisano L, Wrana JL. The TGF-β family and its composite receptors. Trends Cell Biol 1994;4:172-8
30. Vincent P, Plauchu H, Hazan J, et al. A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q. Hum Mol Genet 1995;4:945-9
31. Johnson DW, Berg JN, Gallione CJ, et al. A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. Genome Res 1995;5:21-8
32. McCarthy SA, Bicknell R. Inhibition of vascular endothelial cell growth by activin-A. J Biol Chem 1993;268:23066-71
33. Attisano L, Carcamo F, Ventura F, et al. Identification of human activin and TGF-β type I receptors that form hetomeric kinase complexes with type II receptors. Cell 1993;75:671-80
34. Johnson DW, Berg JN, Baldwin MA, et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996;13:189-95
35. Piantanida M, Buscarini E, Dellavecchia C, et al Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet 1996;33:441-3
36. Heutink P, Haitjema T, Breedveld GJ, et al. Linkage of hereditary haemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity. J Med Genet 1994;31:933-6
37. Porteous ME, Curtis A, Williams O, et al. Genetic heterogeneity in hereditary haemorrhagic telangiectasia. J Med Genet 1994;31:925-6
38. McAllister KA, Lennon F, Bowles BB, et al. Genetic heterogeneity in hereditary haemorrhagic telangiectasia: possible correlation with clinical phenotype. J Med Genet 1994; 31:927-32
39. Berg JN, Guttmacher AE, Marchuk DA, Porteous ME. Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 1996;33:256-7
40. Buscarini E, Buscarini L, Civardi G, et al. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: imaging findings. Am J Roentgenol 1994;163:1105-10
41. Haitjema T, Disch F, Overtoom TT, Westermann CJ, Lammers JW. Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med 1995; 99:519-24
42. White RI, Lynch NA, Terry P, et al. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 1988;169:663-9
43. Fulbright RK, Merriam MA, Fayad PB, et al. Hereditary hemorrhagic telangiectasia: correlation of MR imaging and clinical findings in 130 patients. Radiology 1994;193:211A
44. Bourgeois N, Delcour C, Deviere J, et al. Osler-Weber-Rendu disease associated with hepatic involvement and high output heart failure. J Clin Gastroenterol 1990;12:236-8
45. Hodgson CH, Burchell HB, Good CA, et al. Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous fistula. Survey of a large family. N Engl J Med 1959;261: 625-36
46. Sluiter-Eringa H, Orie NGM, Sluiter HJ. Pulmonary arteriovenous fistula. Diagnosis and prognosis in noncomplainant patients. Am Rev Respir Dis 1969;100:177-86
47. Dutton JA, Jackson JE, Hughes JM, et al. Pulmonary arteriovenous malformations: results of treatment with coil embolization in 53 patients. Am J Roentgenol 1995;165: 1119-25
48. Remy J, Remy JM, Wattinne L, Deffontaines C. Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment [see comments]. Radiology 1992;182:809-16
49. Remy J, Remy JM, Giraud F, Wattinne L. Angioarchitecture of pulmonary arteriovenous malformations: clinical utility of three-dimensional helical CT. Radiology 1994;191: 657-64
50. White RI, Mitchell SE, Barth KH, et al. Angioarchitecture of pulmonary arteriovenous malformations: an important consideration before embolotherapy. Am J Roentgenol 1983;140:681-6
51. White RJ, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: diagnosis and transcatheler embolotherapy. JVIR 1996;7:787-804
52. Chilvers ER, Peters AM, George P, Hughes JM, Allison DJ. Quantification of right to left shunt through pulmonary arteriovenous malformations using 99Tcm albumin microspheres. Clin Radiol 1988;39:611-4
53. Whyte MK, Peters AM, Hughes JM, et al. Quantification of right to left shunt at rest and during exercise in patients with pulmonary arteriovenous malformations. Thorax 1992;47:790-6
54. Ueki J, Hughes JM, Peters AM, et al. Oxygen and 99mTc-MAA shunt estimations in patients with pulmonaty arteriovenous malformations: effects of changes in posture and lung volume. Thorax 1994;49:327-31
55. Barzilai B, Waggoner AD, Spessert C, Picus D, Goodenberger D. Two-dimensional contrast echocardiography in the detection and follow-up of congenital pulmonary arteriovenous malformations: Am J Cardiol 1991;68:1507-10
56. Whyte MK, Hughes JM, Jackson JE, et al. Cardiopulmonary response to exercise in patients with intrapulmonary vascular shunts. J Appl Physiol 1993;75:321-8
57. Sapru RP, Hutchison DCS, Hall JI. Pulmonary hypertension in patients with pulmonary arteriovenous fistulae. Brit Heart J 1969;31:559-69
58. Chow LT, Chow W, Ma K. Pulmonary arteriovenous malformation. Progressive enlargement with replacement of the entire right middle lobe in a patient with mitral stenosis. Med J Aust 1992;158:632-4
59. Pennington DW, Gold WM, Gordon RL, et al. Treatment of pulmonary arteriovenous malformations by therapeutic embolization. Rest and exercise physiology in eight patients. Am Rev Respir Dis 1992;145:1047-51
60. Chilvers ER, Whyte MK, Jackson JE, Allison DJ, Hughes JM. Effect of percutaneous transcatheter embolization on pulmonary function, right-to-left shunt, and arterial oxygenation in patients with pulmonary arteriovenous malformations. Am Rev Respir Dis 1990;142:420-5
61. Wirth JA, Pollak JS, White RI. Pulmonary arteriovenous malformations. In NYA (eds): Current Pulmonary and Critical Care Medicine. NYA: Mosby-Year Book, Inc., St. Louis, MO, 1996;261-98
62. Swinburne AJ, Fedulla AJ, Gangemi R, Mijangos JA. Hereditary telangiectasia and multiple pulmonary arteriovenous fistulas Clinical deterioration during pregnancy. Chest 1986;89:459-60
63. Hughes JMB, Shovlin C, Simonds A. Pulmonary Disease and Cor Pulmonale. In C. Oakley (eds), Heart Disease in Pregnancy. BMJ Publishing Group, London; 1997:180-200
64. Kjeldsen AD, Vase P, Oxhoj H: Hereditary hemorrhagic telangiectasia (letter). N Engl J Med 1996;334:331
65. Terry PB, White RI, Barth KH, Kaufman SL, Mitchell SE. Pulmonary arteriovenous malformations. Physiologic observations and results of therapeutic balloon embolization. N Engl J Med 1983;308:1197-200
66. Jackson JE, Whyte MK, Allison DJ, Hughes JM. Coil embolization of pulmonary arteriovenous malformations. Cor Vasa 1990;32:191-6
67. Haitjema TJ, Overtoom TT, Westermann CJ, Lammers JW. Embolisation of pulmonary arteriovenous malformations: results and follow up in 32 patients. Thorax 1995;50: 719-23
68. Barth KH, White RI, Kaufman SL, Terry PB, Roland JM. Embolotherapy of pulmonary arteriovenous malformations with detachable balloons. Radiology 1982;142:599-606